The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Snail, Slug, and Smad‐interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma
Open accessAbstract
BACKGROUND: It was demonstrated previously that the Snail family of transcription factors and Smad‐interacting protein 1 (Sip1) regulate E‐cadherin and matrix metalloproteinase 2 (MMP‐2) expression, cellular morphology, and invasion in carcinoma. For the current study, the authors analyzed the relation between the expression of Snail, Slug, and Sip1; the expression of MMP‐2 and E‐cadherin; and clinical parameters in patients with metastatic ovarian and breast carcinoma. METHODS: One hundred one fresh‐frozen, malignant effusions from patients who were diagnosed with gynecologic carcinomas (78 ovarian carcinomas and 23 breast carcinomas) were studied for mRNA expression of Snail, Slug, Sip1, MMP‐2, and E‐cadherin using reverse transcriptase‐polymerase chain reaction analysis. Snail mRNA and E‐cadherin protein expression levels also were studied in ovarian carcinoma effusions using in situ hybridization and immunocytochemistry. The results were analyzed for possible correlation with clinicopathologic parameters in both tumor types. RESULTS: E‐cadherin mRNA expression was lower in breast carcinoma (P = 0.001), whereas Snail expression was higher (P = 0.003). The Snail/E‐cadherin ratio (P < 0.001) and the Sip1/E‐cadherin ratio (P = 0.002) were higher in breast carcinomas. Sip1 mRNA expression (P < 0.001) and Slug mRNA expression (P < 0.001) were correlated with the expression of MMP‐2 in ovarian carcinomas. The Sip1/E‐cadherin ratio was higher in primary ovarian carcinomas at the time of diagnosis compared with postchemotherapy ovarian carcinoma effusions (P = 0.003), higher in Stage IV tumors compared with Stage III tumors (P = 0.049), and higher in pleural effusions compared with peritoneal effusions (P = 0.044). In a univariate survival analysis of patients with ovarian carcinoma, a high Sip1/E‐cadherin ratio predicted poor overall survival (P = 0.018). High E‐cadherin mRNA expression predicted better disease‐free survival (P = 0.023), with a similar trend for a low Slug/E‐cadherin ratio (P = 0.07). High Snail mRNA expression predicted shorter effusion‐free survival (P = 0.008), disease‐free survival (P = 0.03), and overall survival (P = 0.008) in patients with breast carcinoma. CONCLUSIONS: Transcription factors that regulate E‐cadherin were expressed differentially in metastatic ovarian and breast carcinoma. Snail may predict a poor outcome in patients who have breast carcinoma metastatic to effusions. E‐cadherin expression generally was conserved in effusions from patients with ovarian carcinoma, but the subset of patients with postulated Sip1‐induced repression of this adhesion molecule had a significantly worse outcome. This finding was in agreement with the stronger suppression of E‐cadherin by Snail and Sip1 in breast carcinoma effusions, a clinical condition associated with extremely poor survival. Cancer 2005. © 2005 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
New functions for the matrix metalloproteinases in cancer progression
Egeblad, M., & Werb, Z. (2002) · Nature Reviews Cancer · doi:10.1038/nrc745 · Cited by 6,108
Cano, A., Pérez-Moreno, M. A., Rodrigo, I., Locascio, A., Blanco, M. J., del Barrio, M. G., Portillo, F., & Nieto, M. A. (2000) · Nature Cell Biology · doi:10.1038/35000025 · Cited by 3,668
Cisplatin: mode of cytotoxic action and molecular basis of resistance
Siddik, Z. H. (2003) · Oncogene · doi:10.1038/sj.onc.1206933 · Cited by 3,335
Cadherin Cell Adhesion Receptors as a Morphogenetic Regulator
Takeichi, M. (1991) · Science · doi:10.1126/science.2006419 · Cited by 3,284
Jemal, A., Murray, T., Samuels, A., Ghafoor, A., Ward, E., & Thun, M. J. (2003) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.53.1.5 · Cited by 3,275
Batlle, E., Sancho, E., Francí, C., Domínguez, D., Monfar, M., Baulida, J., & García de Herreros, A. (2000) · Nature Cell Biology · doi:10.1038/35000034 · Cited by 2,666
The snail superfamily of zinc-finger transcription factors
Nieto, M. A. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm757 · Cited by 1,719
Vleminckx, K., Vakaet, L., Mareel, M., Fiers, W., & Van Roy, F. (1991) · Cell · doi:10.1016/0092-8674(91)90143-m · Cited by 1,656
The cadherins: cell-cell adhesion molecules controlling animal morphogenesis
Takeichi, M. (1988) · Development · doi:10.1242/dev.102.4.639 · Cited by 1,615
The Two-Handed E Box Binding Zinc Finger Protein SIP1 Downregulates E-Cadherin and Induces Invasion
Comijn, J., Berx, G., Vermassen, P., Verschueren, K., van Grunsven, L., Bruyneel, E., Mareel, M., Huylebroeck, D., & van Roy, F. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00260-x · Cited by 1,394
Bolós, V., Peinado, H., Pérez-Moreno, M. A., Fraga, M. F., Esteller, M., & Cano, A. (2003) · Journal of Cell Science · doi:10.1242/jcs.00224 · Cited by 1,100
Role of tissue stroma in cancer cell invasion
De Wever, O., & Mareel, M. (2003) · The Journal of Pathology · doi:10.1002/path.1398 · Cited by 1,042
The SLUG zinc-finger protein represses E-cadherin in breast cancer.
Hajra, K. M., Chen, D. Y., & Fearon, E. R. (2002) · PubMed · Cited by 1,020
Behrens, J., Mareel, M. M., Van Roy, F. M., & Birchmeier, W. (1989) · The Journal of cell biology · doi:10.1083/jcb.108.6.2435 · Cited by 946
Inactivation of the E-Cadherin-Mediated Cell Adhesion System in Human Cancers
Hirohashi, S. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65575-7 · Cited by 839
Correlation of Snail expression with histological grade and lymph node status in breast carcinomas
Blanco, M. J., Moreno-Bueno, G., Sarrio, D., Locascio, A., Cano, A., Palacios, J., & Nieto, M. A. (2002) · Oncogene · doi:10.1038/sj.onc.1205416 · Cited by 576
Rosivatz, E., Becker, I., Specht, K., Fricke, E., Luber, B., Busch, R., Höfler, H., & Becker, K.-F. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64464-1 · Cited by 572
Berx, G., & Roy, F. V. (2001) · Breast Cancer Research · doi:10.1186/bcr309 · Cited by 463
Microtubule-targeted anticancer agents and apoptosis
Bhalla, K. N. (2003) · Oncogene · doi:10.1038/sj.onc.1207233 · Cited by 461
Kosary, C. L. (1994) · Seminars in Surgical Oncology · doi:10.1002/ssu.2980100107 · Cited by 417
Cadherin and catenin alterations in human cancer
Hajra, K. M., & Fearon, E. R. (2002) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.10083 · Cited by 380
Imai, T., Horiuchi, A., Wang, C., Oka, K., Ohira, S., Nikaido, T., & Konishi, I. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63501-8 · Cited by 377
Snail/Slug family of repressors: slowly going into the fast lane of development and cancer
Hemavathy, K., Ashraf, S. I., & Ip, Y. T. (2000) · Gene · doi:10.1016/s0378-1119(00)00371-1 · Cited by 299
Cadherins and Catenins: Role in Signal Transduction and Tumor Progression
Behrens, J. (1999) · Cancer and Metastasis Reviews · doi:10.1023/a:1006200102166 · Cited by 286
Snail and SIP1 increase cancer invasion by upregulating MMP family in hepatocellular carcinoma cells
Miyoshi, A., Kitajima, Y., Sumi, K., Sato, K., Hagiwara, A., Koga, Y., & Miyazaki, K. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601685 · Cited by 284
Mutations of the E–cadherin gene in human gynecologic cancers
Risinger, J. I., Berchuck, A., Kohler, M. F., & Boyd, J. (1994) · Nature Genetics · doi:10.1038/ng0594-98 · Cited by 280
Poser, I., Domı́nguez, D., de Herreros, A. G., Varnai, A., Buettner, R., & Bosserhoff, A. K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011224200 · Cited by 280
E-cadherin mediated adhesion system in cancer cells
Shiozaki, H., Oka, H., Inoue, M., Tamura, S., & Monden, M. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960415)77:8<1605::aid-cncr28>3.0.co;2-2 · Cited by 277
Remacle, J. E. (1999) · The EMBO Journal · doi:10.1093/emboj/18.18.5073 · Cited by 276
Defective E-cadherin/catenin complexes in human cancer
Van Aken, E., De Wever, O., da Rocha, C. A., & Mareel, M. (2001) · Virchows Archiv · doi:10.1007/s004280100516 · Cited by 250
Cheng, C.-W., Wu, P.-E., Yu, J.-C., Huang, C.-S., Yue, C.-T., Wu, C.-W., & Shen, C.-Y. (2001) · Oncogene · doi:10.1038/sj.onc.1204505 · Cited by 221
Makar, A. P., Baekelandt, M., Tropé, C. O., & Kristensen, G. B. (1995) · Gynecologic Oncology · doi:10.1006/gyno.1995.1027 · Cited by 219
Self-citationBukholm, I. K., Nesland, J. M., & B�rresen-Dale, A.-L. (2000) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(200001)190:1<15::aid-path489>3.0.co;2-l · Cited by 208
Self-citationYokoyama, K., Kamata, N., Hayashi, E., Hoteiya, T., Ueda, N., Fujimoto, R., & Nagayama, M. (2001) · Oral Oncology · doi:10.1016/s1368-8375(00)00059-2 · Cited by 208
Yokoyama, K., Kamata, N., Fujimoto, R., Tsutsumi, S., Tomonari, M., Taki, M., Hosokawa, H., & Nagayama, M. (2003) · International Journal of Oncology · doi:10.3892/ijo.22.4.891 · Cited by 195
Davidson, B., Goldberg, I., Gotlieb, W. H., Kopolovic, J., Ben-Baruch, G., Nesland, J. M., Berner, A., Bryne, M., & Reich, R. (1999) · Clinical & Experimental Metastasis · doi:10.1023/a:1006723011835 · Cited by 183
Self-citationLombardi, G., Zustovich, F., Nicoletto, M. O., Donach, M., Artioli, G., & Pastorelli, D. (2010) · American Journal of Clinical Oncology · doi:10.1097/coc.0b013e3181aacbbf · Cited by 169
Davidson, B., Nielsen, S., Christensen, J., Asschenfeldt, P., Berner, A., Risberg, B., & Johansen, P. (2001) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200111000-00008 · Cited by 165
Self-citationJiao, W., Miyazaki, K., & Kitajima, Y. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600017 · Cited by 154
Detection of cancer cells in effusions from patients diagnosed with gynaecological malignancies
Davidson, B., Risberg, B. Å., Kristensen, G. B., Kvalheim, G., Emilsen, E., Bjåmer, A., & Berner, A. (1999) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s004280050393 · Cited by 100
Self-citationLambert, C. A., Colige, A., Munaut, C., Lapiere, C. M., & Nusgens, B. (2001) · Matrix Biology · doi:10.1016/s0945-053x(01)00156-1 · Cited by 97
Granulin‐epithelin precursor is a novel prognostic marker in epithelial ovarian carcinoma
Davidson, B., Alejandro, E. U., Flørenes, V. A., Goderstad, J. M., Risberg, B. Å., Kristensen, G. B., Trope, C. G., & Kohn, E. C. (2004) · Cancer · doi:10.1002/cncr.20219 · Cited by 95
Self-citationDavidson, B., Reich, R., Lazarovici, P., Flørenes, V. A., Nielsen, S. M., & Nesland, J. M. (2004) · Breast Cancer Research and Treatment · doi:10.1023/b:brea.0000010704.17479.8a · Cited by 81
Self-citationKitazume, H., Kitamura, K., Mukai, K., Inayama, Y., Kawano, N., Nakamura, N., Sano, J., Mitsui, K., Yoshida, S., & Nakatani, Y. (2000) · Cancer · doi:10.1002/(sici)1097-0142(20000225)90:1<55::aid-cncr8>3.0.co;2-p · Cited by 80
Ovarian carcinoma cells in serous effusions show altered MMP-2 and TIMP-2 mRNA levels
Davidson, B., Reich, R., Berner, A., Givant-Horwitz, V., Goldberg, I., Risberg, B. Å., Kristensen, G. B., Trope, C. G., Bryne, M., Kopolovic, J., et al. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00235-0 · Cited by 68
Self-citationDavidson, B., Konstantinovsky, S., Nielsen, S. M., Dong, H. P., Berner, A., Vyberg, M., & Reich, R. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0183 · Cited by 66
Self-citationGivant-Horwitz, V., Davidson, B., Lazarovici, P., SCHAEFER, E. M., Nesland, J. M., Trope, C. G., & Reich, R. (2003) · Gynecologic Oncology · doi:10.1016/s0090-8258(03)00434-7 · Cited by 58
Self-citationEffusion cytology in ovarian cancer: new molecular methods as aids to diagnosis and prognosis
Davidson, B., Risberg, B. Å., Reich, R., & Berner, A. (2003) · Clinics in Laboratory Medicine · doi:10.1016/s0272-2712(03)00058-1 · Cited by 43
Self-citationClassical cadherin and catenin expression in normal myometrial tissues and uterine leiomyomas
Tai, C., Lin, W., Chang, W., Chiu, T., & Chen, G. T. C. (2002) · Molecular Reproduction and Development · doi:10.1002/mrd.10248 · Cited by 17
Cited by
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
Polyak, K., & Weinberg, R. A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2620 · Cited by 3,302
Snail, Zeb and bHLH factors in tumour progression: An alliance against the epithelial phenotype?
Peinado, H., Olmeda, D., & Cano, A. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2131 · Cited by 3,121
Park, S.-M., Gaur, A. B., Lengyel, E., & Peter, M. E. (2008) · Genes & Development · doi:10.1101/gad.1640608 · Cited by 2,272
Ovarian Cancer Development and Metastasis
Lengyel, E. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.100105 · Cited by 1,672
The Snail genes as inducers of cell movement and survival: implications in development and cancer
Barrallo-Gimeno, A., & Nieto, M. A. (2005) · Development · doi:10.1242/dev.01907 · Cited by 1,394
Metadata
- Authors
- Elloul, S., Bukholt Elstrand, M., Nesland, J. M., Tropé, C. G., Kvalheim, G., Goldberg, I., Reich, R., & Davidson, B.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2005-03
- Volume
- 103
- Issue
- 8
- Pages
- 1631-1643
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W1965255998
- Cited by
- 429
- References
- 50
- FWCI
- 9.61
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.